Clinical trialNCT04411602WithdrawnPhase 1Interventional

Intermediate IND Severe Illness COVID-19 CP

SponsorHenry Ford Health SystemEnrollment0COVIDSevere Acute Respiratory Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Beyond supportive care, there are currently no proven therapeutic options for pneumonia due to coronavirus disease (COVID-19), the infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Human convalescent plasma is an option for treatment of COVID-19 and will be available when sufficient numbers of people have recovered. Such persons should have high titer neutralizing immunoglobulin-containing plasma.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Debra J Levan, DO
Ascension Macomb-Oakland Hospital, Warren Campus
Principal Investigator
clinicaltrials.gov ↗
Shukri David, MD
Ascension Providence Hospital, Southfield Campus
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ascension Providence Hospital, Novi Campus
Novi, Michigan, United States
Ascension Providence Hospital, Southfield Campus
Southfield, Michigan, United States
Ascension Macomb-Oakland Hospital, Warren Campus
Warren, Michigan, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

SARS-CoV-2 plasma

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Apr 2020
Primary completion: 7 Apr 2021
Completion: 7 Apr 2021
Last update posted: 19 Dec 2025
Registered enrollment: 0
Registry id: NCT04411602

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.